Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
---|
01/19/2012 | US20120014956 Methods and compositions for predicting responsiveness to treatment with tnf-alpha inhibitor |
01/19/2012 | US20120014949 Serum Biomarkers For Early Detection Of Acute Cellular Rejection |
01/19/2012 | US20120014948 Genetic products differentially expressed in tumors and use thereof |
01/19/2012 | US20120014945 Anti-Dengue Virus Antibodies |
01/19/2012 | US20120014942 Method for the diagnosis and prognosis of malignant diseases |
01/19/2012 | US20120014937 Human Beta-Adrenergic receptor kinase polypeptide and methods |
01/19/2012 | US20120014927 Methods and kits for determining predisposition to cancer |
01/19/2012 | US20120014881 Methods for detecting a mycobacterium tuberculosis infection |
01/19/2012 | US20120014879 USE OF TUMOR NECROSIS FACTOR-alpha RECEPTOR p75 FOR TREATMENT OF ISCHEMIA-INDUCED NEOVASCULARIZATION |
01/19/2012 | US20120014872 Novel Method of Diagnosing, Monitoring, Staging, Imaging and Treating Various Cancers |
01/19/2012 | US20120014870 Diagnosis and Treatment of Cancer Using Anti-LGR7 Antibody |
01/19/2012 | US20120014836 Manipulation of magnetic particles in a biological sample |
01/19/2012 | US20120014748 Novel soil diagnosis method |
01/19/2012 | US20120014409 Dampening Apparatus and Method for Single Piston Pump Used in Determining the Thermal Stability of Fluids |
01/19/2012 | US20120014408 Detecting a Short in an Apparatus and Method for Determining the Thermal Stability of Fluids |
01/19/2012 | US20120014407 Auto Priming and Flushing an Apparatus for Determining the Thermal Stability of Fluids |
01/19/2012 | US20120014406 Containers used in determining the thermal stability of fuels |
01/19/2012 | US20120014405 Drop Counter And Flow Meter For Apparatus And Method For Determining The Thermal Stability Of Fluids |
01/19/2012 | US20120014404 Apparatus and Method for Determining the Thermal Stability of Fluids |
01/19/2012 | US20120012472 Novel chemistry used in biosensors |
01/19/2012 | US20120012462 Electrophoresis Chip and Electrophoresis Apparatus |
01/19/2012 | US20120011705 Integrated lancet and bodily fluid sensor |
01/19/2012 | DE10243510B4 Vorrichtung zur Zustandsbestimmung von Öl Apparatus for determining the state of oil |
01/19/2012 | DE102011007740A1 Diagnosing Alzheimer's disease using phototransistor, involves placing phototransistor in place, fixing cells on surface of channel layer, and sensing difference of photocurrents induced by cells |
01/19/2012 | DE102010031536A1 Prüfverfahren für Hopfen und Extrakte davon Test methods for hops and extracts thereof |
01/19/2012 | DE102010031528A1 System for determination of primary energy contents of e.g. wood in chopped goods form or substitute fuel, has evaluating device determining primary energy contents of fuel under consideration of determined water contents of fuel |
01/19/2012 | DE102010027488A1 Device for receiving and transporting biopsy sample of tissue of living organism to investigation location, has container loaded with sample via opening, and wire vessel releasably integrated into container for receiving sample in container |
01/19/2012 | DE102010027074A1 Verfahren und Vorrichtung zur Detektion von Sprengstoffpartikeln in einem Gasstrom Method and apparatus for detecting explosive particles in a gas stream |
01/19/2012 | DE102010026967A1 Irreversible thermochromic dye for e.g. lubricating oil of machine, has metal nanoparticles that are arranged such that surface plasmon resonance of nanoparticles is irreversibly altered according to temperature change of oil |
01/19/2012 | DE102008050530B4 Verfahren zur gemeinsamen verwechslungssicheren Handhabung von Objektträgern und mindestens einer Probenkassette Process for the common confusion safe handling of slides and at least one sample cartridge |
01/19/2012 | DE10126053B4 Mikrofiltration Microfiltration |
01/19/2012 | CA2805586A1 A method of analysing a blood sample of a subject for the presence of a disease marker |
01/19/2012 | CA2805560A1 Protein binding domains stabilizing functional conformational states of gpcrs and uses thereof |
01/19/2012 | CA2805414A1 Anti-addl monoclonal antibody and uses thereof |
01/19/2012 | CA2805306A1 Diagnostic method for colitis |
01/19/2012 | CA2805300A1 Human papillomavirus e7 antigen compositions and uses thereof |
01/19/2012 | CA2805249A1 Methods and systems for in vivo clinical data measurement of analytes |
01/19/2012 | CA2805238A1 Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
01/19/2012 | CA2804904A1 Fgl-2 prothrombinase as a diagnostic tool for malignancy |
01/19/2012 | CA2804802A1 Biomarkers for diagnosis of stroke and its causes |
01/19/2012 | CA2804763A1 Biomarkers for diagnosis of transient ischemic attacks |
01/19/2012 | CA2804746A1 Novel methods of protein evolution |
01/19/2012 | CA2803944A1 Method for the isolation of proteins binding to any kind nucleic acid sequence of interest |
01/19/2012 | CA2802747A1 Method of assessing risk of multiple births in infertility treatments |
01/19/2012 | CA2802404A1 Pharmaceutical form for combating chemical submission of a medicament |
01/19/2012 | CA2801996A1 Novel antibody for the diagnosis and/or prognosis of cancer |
01/19/2012 | CA2746891A1 Fluorescent markers and use thereof for labelling specific protein targets |
01/18/2012 | EP2407788A1 Method for measuring biogenous biologically active substances, a program for implementing the same, and apparatus for measuring biogenous biologically active substances |
01/18/2012 | EP2407787A2 Method for detection of L523S expression in biological samples |
01/18/2012 | EP2407786A1 Method for predicting therapeutic efficacy of chemotherapy on non-small-cell lung cancer |
01/18/2012 | EP2407785A1 Selection by compartmentalised screening |
01/18/2012 | EP2407784A1 Method for detecting muscle degenerative diseases, and method for determining therapeutic efficacy on the diseases |
01/18/2012 | EP2407783A1 A method for pharmacologically profiling compounds |
01/18/2012 | EP2407782A1 Method and assay for glycosylation pattern detection related to cell state |
01/18/2012 | EP2407781A1 Cell observation apparatus and observation method |
01/18/2012 | EP2407776A1 Sensor for fluid and/or gas analysis |
01/18/2012 | EP2407775A1 Biosensor and biosensor manufacturing method |
01/18/2012 | EP2407768A1 Hard particle concentration detection method, particle concentration detection method, and device therefor |
01/18/2012 | EP2407562A1 Systems and methods for developing diagnostic tests based on biomarker information from legacy clinical sample sets |
01/18/2012 | EP2407556A1 Method for determining sensitivity to irinotecan and use thereof |
01/18/2012 | EP2407553A1 Gene Expression Markers for Colorectal Cancer Prognosis |
01/18/2012 | EP2407552A1 New method for the isolation of the proteins bound to any kind of interesting nucleic acid sequence |
01/18/2012 | EP2407550A1 Cell separation method |
01/18/2012 | EP2407538A1 Reporter vector for use in evaluation of CYP1A2 |
01/18/2012 | EP2407486A1 Antagonist antibodies against GDF-8 and uses in treatment of ALS and other GDF-8-associated disorders |
01/18/2012 | EP2407245A2 Kit for centrifugal separation, and centrifugal separation method using same |
01/18/2012 | EP2407095A1 Analyte sensor |
01/18/2012 | EP2407094A1 Analyte sensor |
01/18/2012 | EP2407093A1 Analyte sensor |
01/18/2012 | EP2406728A1 A method for identification, prediction and prognosis of cancer aggressiveness |
01/18/2012 | EP2406639A2 Strobo thin film chemical analysis apparatus and assay method using the same |
01/18/2012 | EP2406637A1 Diagnosis of neuropsychiatric and behavioural disorders |
01/18/2012 | EP2406636A2 Methods of diagnosing and predicting renal disease |
01/18/2012 | EP2406635A1 A method for predicting the responsiveness to an anti-tnf alpha antibody treatment |
01/18/2012 | EP2406634A2 Deuterium isobaric tag reagents for quantitative analysis |
01/18/2012 | EP2406633A1 Compositions and methods for characterizing arthritic conditions |
01/18/2012 | EP2406632A1 Sensitive method to analyse free peg-maleimide |
01/18/2012 | EP2406631A1 Improvement of tumour treatment |
01/18/2012 | EP2406630A1 Immunoassays employing non-particulate chemiluminescent reagent |
01/18/2012 | EP2406629A1 Immuno-based retargeted endopeptidase activity assays |
01/18/2012 | EP2406628A1 Method or system using biomarkers for the monitoring of a treatment |
01/18/2012 | EP2406627A2 A pkn3/rhoc macromolecular complex and methods of use therefor |
01/18/2012 | EP2406626A1 Method and means for detecting the activity of osteoclasts |
01/18/2012 | EP2406621A1 Electrical sensor for ultrasensitive nucleic acid detection |
01/18/2012 | EP2406620A1 Device for providing a means for internal calibration in an electrochemical sensor |
01/18/2012 | EP2406617A1 Methods and systems of imaging cut stones |
01/18/2012 | EP2406614A1 Apparatus for processing a biological and/or chemical sample |
01/18/2012 | EP2406613A1 Method and system for the measurement/detection of chemical spillage |
01/18/2012 | EP2406612A2 Optical cell assembly, cartridge and apparatus |
01/18/2012 | EP2406580A2 Optical tomography system with high-speed scanner |
01/18/2012 | EP2406401A2 Methods of identification, assessment, prevention and therapy of lung diseases and kits thereof including gender-based disease identification, assessment, prevention and therapy |
01/18/2012 | EP2406397A2 Method |
01/18/2012 | EP2406390A1 Automated method for detecting cancers and high grade hyperplasias |
01/18/2012 | EP2406389A1 Methods and compositions for cell-proliferation-related disorders |
01/18/2012 | EP2406374A1 Controllable assembly and disassembly of nanoparticle systems via protein and dna agents |
01/18/2012 | EP2406371A1 Cells useful for immuno-based botulinum toxin serotype a activity assays |
01/18/2012 | EP2406325A2 Faecal markers |
01/18/2012 | EP2406287A1 Antibodies binding to pivka-ii amino acids 13-27 |
01/18/2012 | EP2406285A1 Generation, expression and characterization of the humanized k33n monoclonal antibody |
01/18/2012 | EP2406279A2 Compositions and methods for prevention and treatment of neurodegenerative diseases |